| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.35 | 3e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.12 | 5e-05 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-05 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0005 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0008 |